Scholars Central

ArticlePublished 2013

Therapeutic Strategies in the Second Line Setting of Advanced or Metastatic Pancreatic Adenocarcinoma

Authors: Muhammad Wasif Saif, Kostas N Syrigos, Vasilis Stefanos Ramfidis

Journal of the Pancreas

Volume 14 · Issue 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic cancer is a lethal disease and its prognosis remains dismal. The modest results of existing available treatments inthe second line setting reveal the need of new therapeutic strategies. In this year’s American Society of Clinical Oncology(ASCO) Annual Meeting two remarkable trials and one retrospective analysis were presented regarding this vulnerablegroup of patients. According to the published results, docetaxel plus oxaliplatin (Abstract #4034), selumetinib plus erlotinib(Abstract #4014) and nab-paclitaxel (Abstract #e15057) have shown promising efficacy and manageable toxicity that shouldbe elucidated and confirmed by new prospective, large, randomized trials.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Muhammad Wasif Saif”
  • BylineArticles whose byline prints “Kostas N Syrigos”
  • BylineArticles whose byline prints “Vasilis Stefanos Ramfidis”